- US-listed companies
- Jaguar Health, Inc.
- Income statement
Jaguar Health, Inc. (JAGX) Income statement
Market cap
$42.83M
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 258,381 | 141,523 | 4 | 4 | 6 | 9 | - | 12 | - | 12 | 12 |
| Revenue growth (%) | - | - | - | - | - | ||||||
| Cost of revenue | 123,457 | 51,966 | 880,405 | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 4 |
| Research & development | 6 | 7 | 4 | 5 | 6 | 6 | 15 | 18 | 19 | 17 | 25 |
| Operating margin (%) | - | - | |||||||||
| Operating expenses | 13 | 14 | 39 | 35 | 35 | 36 | 45 | 46 | 44 | 43 | 57 |
| Operating income | -12,445,369 | -13,585,985 | -34,247,060 | -30,823,968 | -28,948,111 | -27 | -41 | -34 | -34 | -31 | -46 |
| Income before tax | - | - | -35,149,856 | -32,146,057 | -38,529,436 | -34 | -53 | -48 | -42 | -39 | -54 |
| Pretax margin (%) | - | - | -806 | -727.9 | -667.1 | -360.1 | - | -404.8 | - | -335.8 | -469.1 |
| Provision for income taxes | - | - | -13,181,242 | - | 10,000 | - | - | - | - | - | - |
| Effective tax rate (%) | - | - | - | - | - | - | - | - | - | ||
| Net income | -16,291,550 | -14,733,780 | -21,968,614 | -32,146,057 | -38,539,436 | -34 | -53 | -48 | -42 | -39 | -54 |
| Net income margin (%) | - | - | |||||||||
| Earnings per share | - | - | - | - | - | - | -1.18 | -36.18 | -1.79 | -130.69 | -22.97 |
| Diluted EPS | - | - | - | - | - | - | -1.18 | -36.18 | -1.79 | -130.69 | -22.97 |
| EBITDA | |||||||||||
| EBITDA margin (%) | - | - |